These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 12894229)
1. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site. Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229 [TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. Gougelet A; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells. Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Pettersson K; Delaunay F; Gustafsson JA Oncogene; 2000 Oct; 19(43):4970-8. PubMed ID: 11042684 [TBL] [Abstract][Full Text] [Related]
6. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Hall JM; McDonnell DP Endocrinology; 1999 Dec; 140(12):5566-78. PubMed ID: 10579320 [TBL] [Abstract][Full Text] [Related]
7. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line. Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406 [TBL] [Abstract][Full Text] [Related]
8. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Lee TH; Chuang LY; Hung WC Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931 [TBL] [Abstract][Full Text] [Related]
9. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene. Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999 [TBL] [Abstract][Full Text] [Related]
12. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292 [TBL] [Abstract][Full Text] [Related]
13. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes. Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325 [TBL] [Abstract][Full Text] [Related]
15. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells. Smith LH; Coats SR; Qin H; Petrie MS; Covington JW; Su M; Eren M; Vaughan DE Circ Res; 2004 Aug; 95(3):269-75. PubMed ID: 15217907 [TBL] [Abstract][Full Text] [Related]
16. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation. Power KA; Thompson LU Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916 [TBL] [Abstract][Full Text] [Related]
17. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Schwartz JA; Liu G; Brooks SC Biochem Biophys Res Commun; 1998 Dec; 253(1):38-43. PubMed ID: 9875216 [TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line. Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895 [TBL] [Abstract][Full Text] [Related]
19. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Kim K; Thu N; Saville B; Safe S Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490 [TBL] [Abstract][Full Text] [Related]